Clinical trial
Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects…
NCT00427674 · Institute for Neurodegenerative Disorders, Other · Terminated
Key facts
| NCT number | NCT00427674 |
|---|---|
| Title | Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects and Parkinson Disease Patients |
| Official title | Phase I Evaluation of (123-I)MZINT as a Brain SPECT Tracer of Serotonin Transporters in Healthy Human Subjects |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | Molecular NeuroImaging |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | [123I] mZINT injection and serial dynamic SPECT imaging |
| Enrollment | 28 |
| Start date | Jan 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Jan 29, 2007 |
| Last update posted | Oct 6, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: